T2D Might Increase Risk of Post Colonoscopy Colorectal Cancer: BMC
Post-colonoscopy colorectal cancer (PCCRC), a term endorsed by the World Endoscopy Organization, refers to colorectal cancers (CRCs) diagnosed after a negative colonoscopy with a prevalence of up to 8% of all colorectal cancers. A recent study suggests that patients with type 2 diabetes (T2D) have an increased relative risk of post-colonoscopy colorectal cancers compared with patients without T2D. The study findings were published in the journal BMJ Open Gastroenterology on December 24, 2021.
Studies have shown that patients with T2D are at particularly high risk of CRC. However, evidence regarding the impact of T2D on the risk of PCCRC is needed to improve the overall colonoscopy quality and to guide clinical decision making, particularly for planning surveillance colonoscopies for patients with T2D within CRC screening programmes. Therefore, Dr Frederikke Schønfeldt Troelsen and his team conducted a study to investigate whether patients with T2D are at increased risk of PCCRC compared with patients without T2D.
The researchers conducted a population-based cohort study of patients with T2D and without T2D undergoing colonoscopy in Denmark (1995–2015). Among 362263 patients undergoing colonoscopy, the researchers observed 250 PCCRCs among patients with T2D and 1658 PCCRCs among patients without T2D. They assessed the risk of PCCRC by calculating >6 to 36 months cumulative incidence proportions (CIPs) treating, death and colectomy as competing risks. They evaluated the HRs of PCCRC, comparing patients with T2D and non-T2D using Cox proportional-hazards regression analyses. According to the World Endoscopy Organization guidelines, they calculated PCCRC 3-year rates to estimate the proportions of T2D and non-T2D CRC patients experiencing PCCRC.
Key findings of the study:
- Upon analysis, the researchers found that the CIP after a first-time colonoscopy was 0.64% or T2D and 0.36% for patients without T2D.
- Compared with patients without T2D, they noted that those with T2D had elevated aHRs of PCCRC after the first colonoscopy (1.44) and second colonoscopy (1.18).
- They observed that the PCCRC rates at 3 years were 7.9% for patients with T2D vs 7.4% without T2D.
The authors concluded, "We found that patients with T2D had an increased HR of PCCRC compared with patients without T2D. These findings could indicate that impaired quality of bowel preparation for colonoscopy among patients with T2D may increase the risk of overlooked precancerous polyps, thereby increasing the risk of PCCRC."
For further information:
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd